1. Home
  2. TPST vs VBIX Comparison

TPST vs VBIX Comparison

Compare TPST & VBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TPST
  • VBIX
  • Stock Information
  • Founded
  • TPST 2011
  • VBIX N/A
  • Country
  • TPST United States
  • VBIX Israel
  • Employees
  • TPST N/A
  • VBIX N/A
  • Industry
  • TPST Biotechnology: Pharmaceutical Preparations
  • VBIX Computer Software: Prepackaged Software
  • Sector
  • TPST Health Care
  • VBIX Technology
  • Exchange
  • TPST Nasdaq
  • VBIX Nasdaq
  • Market Cap
  • TPST 33.0M
  • VBIX 26.4M
  • IPO Year
  • TPST N/A
  • VBIX N/A
  • Fundamental
  • Price
  • TPST $6.85
  • VBIX $5.34
  • Analyst Decision
  • TPST Hold
  • VBIX
  • Analyst Count
  • TPST 3
  • VBIX 0
  • Target Price
  • TPST $30.00
  • VBIX N/A
  • AVG Volume (30 Days)
  • TPST 86.6K
  • VBIX 128.0K
  • Earning Date
  • TPST 08-07-2025
  • VBIX 08-14-2025
  • Dividend Yield
  • TPST N/A
  • VBIX N/A
  • EPS Growth
  • TPST N/A
  • VBIX N/A
  • EPS
  • TPST N/A
  • VBIX N/A
  • Revenue
  • TPST N/A
  • VBIX $19,672,000.00
  • Revenue This Year
  • TPST N/A
  • VBIX N/A
  • Revenue Next Year
  • TPST N/A
  • VBIX N/A
  • P/E Ratio
  • TPST N/A
  • VBIX N/A
  • Revenue Growth
  • TPST N/A
  • VBIX N/A
  • 52 Week Low
  • TPST $5.35
  • VBIX $0.18
  • 52 Week High
  • TPST $30.03
  • VBIX $12.00
  • Technical
  • Relative Strength Index (RSI)
  • TPST 47.98
  • VBIX N/A
  • Support Level
  • TPST $6.88
  • VBIX N/A
  • Resistance Level
  • TPST $7.64
  • VBIX N/A
  • Average True Range (ATR)
  • TPST 0.26
  • VBIX 0.00
  • MACD
  • TPST -0.01
  • VBIX 0.00
  • Stochastic Oscillator
  • TPST 29.25
  • VBIX 0.00

About TPST Tempest Therapeutics Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

About VBIX Viewbix Inc. Common Stock

ViewBix Inc operates in the field of digital advertising. Along with its subsidiaries, the company performs two main activities that are reported as separate operating segments: the search segment and the digital content segment. Maximum revenue is generated from the digital content segment, which is engaged in the creation and editing of content, in different languages, for different target audiences, to generate revenues from advertising platforms, including Google, Facebook, Yahoo, and Apple, by utilizing such content to obtain internet user traffic for its customers. The search segment develops various technological software solutions, which perform automation, optimization, and monetization of internet campaigns, to obtain and route internet user traffic to its customers.

Share on Social Networks: